Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene.
about
Gene therapy for ischemic heart diseaseGene Therapy for Cardiovascular DiseaseHeme oxygenase-1 and carbon monoxide in pulmonary medicineHaeme oxygenase signalling pathway: implications for cardiovascular diseaseTargeting survival pathways to create infarct-spanning bridges of human embryonic stem cell-derived cardiomyocytes.The association between heme oxygenase-1 gene promoter polymorphism and the outcomes of catheter ablation of atrial fibrillationHeme oxygenase-1 induction improves cardiac function following myocardial ischemia by reducing oxidative stressA single direct injection into the left ventricular wall of an adeno-associated virus 9 (AAV9) vector expressing extracellular superoxide dismutase from the cardiac troponin-T promoter protects mice against myocardial infarction.α-Lipoic acid reduces infarct size and preserves cardiac function in rat myocardial ischemia/reperfusion injury through activation of PI3K/Akt/Nrf2 pathway.High resolution optical imaging of infarction in intact organsUp-regulation of heme oxygenase-1 after infarct initiation reduces mortality, infarct size and left ventricular remodeling: experimental evidence and proof of concept.Cobalt protoporphyrin pretreatment protects human embryonic stem cell-derived cardiomyocytes from hypoxia/reoxygenation injury in vitro and increases graft size and vascularization in vivo.Cardiac stem cell therapy for cardiac repair.Translational Significance of Heme Oxygenase in Obesity and Metabolic SyndromeThe role of Nrf2-mediated pathway in cardiac remodeling and heart failure.Cardioprotective and antiapoptotic effects of heme oxygenase-1 in the failing heart.Targeting heme oxygenase-1 in vascular diseaseHeme oxygenase-1 induction enhances cell survival and restores contractility to unvascularized three-dimensional adult cardiomyocyte grafts implanted in vivo.Applied gene therapy in preclinical models of vascular injury.Role of heme oxygenase-1 in the regulation of blood pressure and cardiac function.AAV vectors for cardiac gene transfer: experimental tools and clinical opportunities.Transduced PEP-1-heme oxygenase-1 fusion protein reduces remote organ injury induced by intestinal ischemia/reperfusion.Protective Effect of Sevoflurane Postconditioning against Cardiac Ischemia/Reperfusion Injury via Ameliorating Mitochondrial Impairment, Oxidative Stress and Rescuing Autophagic Clearance.Protective role of heme oxygenase in the blood vessel wall during atherogenesis.Fumarate is cardioprotective via activation of the Nrf2 antioxidant pathway.Can Cytoprotective Cobalt Protoporphyrin Protect Skeletal Muscle and Muscle-derived Stem Cells From Ischemic Injury?Loss of Akt activity increases circulating soluble endoglin release in preeclampsia: identification of inter-dependency between Akt-1 and heme oxygenase-1.Cell-selective viral gene delivery vectors for the vasculature.HO-1 Protects against Hypoxia/Reoxygenation-Induced Mitochondrial Dysfunction in H9c2 Cardiomyocytes.In vivo regulation of the heme oxygenase-1 gene in humanized transgenic miceAdeno-associated virus vectors: potential applications for cancer gene therapy.The heme oxygenase 1 inducer (CoPP) protects human cardiac stem cells against apoptosis through activation of the extracellular signal-regulated kinase (ERK)/NRF2 signaling pathway and cytokine releaseChronic phospholamban inhibition prevents progressive cardiac dysfunction and pathological remodeling after infarction in rats.Molecular aspects of ischemic heart disease: ischemia/reperfusion-induced genetic changes and potential applications of gene and RNA interference therapy.Role of carbon monoxide in cardiovascular function.Creation of a cardiotropic adeno-associated virus: the story of viral directed evolution.Gene and cell therapy for chronic ischaemic heart disease.Reduction of experimental diabetic vascular leakage by delivery of angiostatin with a recombinant adeno-associated virus vectorResveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin, and heme oxygenase.Secoisolariciresinol diglucoside induces neovascularization-mediated cardioprotection against ischemia-reperfusion injury in hypercholesterolemic myocardium.
P2860
Q24632135-9DF5AFFE-7021-4C69-8A00-FBB673488C0FQ24791063-4343D6DB-23FB-47A9-AB61-FE8478EACA2CQ24797238-6FA0550A-0DD5-4330-B21A-6B73736525E1Q27002692-7AB14038-8252-40C6-8893-F8DC0110807BQ27308987-3D88F714-D9CC-4E1F-AF03-71FA8C026A8FQ28486285-55DCC0C0-E74D-4E20-9FFC-D78C0018D4E2Q28541319-8C6A4F96-50CE-49A7-97A2-D92F02EC47AFQ30413864-E6E865C8-1D40-4CAB-B3D6-BB2AA8EDF872Q30457378-8A31E876-520F-4B1E-B31F-A0393A6EC5C3Q30495603-43A777A1-30EA-40E3-A900-2F9BCAC3559CQ30578202-899CE817-D432-4C33-879C-EC0AB3A08B00Q33690013-43722A05-5D82-4013-B748-E55AB8D9A0B2Q33749374-46D24FB5-4182-4AE0-A769-841C3A9239C1Q33847244-C14B48E1-0510-4246-BD4B-F77F36C6293EQ33914944-12C36786-5C80-4CDF-BBD6-CE2D218E9D21Q34049082-842AF076-B3C3-4CE9-8750-3568788C62DAQ34299531-B1B61922-FE26-47B6-A0AB-9A191DF66FB8Q34995661-BF7CD2D0-09CB-495E-ADF2-6FCF57FF8630Q35095408-8C0CE848-7465-486A-B156-E2045B144B95Q35112576-B8AC2469-B3BE-4402-B415-A2235400FB7AQ35238264-71AF2EF5-B1C9-447F-9415-B4FDB7FF5EC7Q35505641-2AB301C4-F819-4EBC-B05B-F79B09667C3FQ35742639-80D2FD4C-3052-4FBA-AC0A-2B61EE23752FQ35794768-BD5542B6-3D66-4D29-B9C2-F794901ACFA7Q35859412-70FBC9C0-8982-4056-B0C4-1ADF77472DFDQ35912367-E3284393-F7EA-4BBE-9FE7-055A6DF6A09CQ35926413-9C8F55C2-CA52-4C50-AADC-60650B8751A4Q35948498-9B5241BE-141B-4397-86FB-988F0D2F78A4Q36006571-70AF7E53-F766-4C4C-BBF1-521CD9139994Q36094903-FD23D7B0-B749-453D-8D78-466879236460Q36165834-1163E678-818B-41D1-B9FD-4425B8A9DE7AQ36286171-870EB142-384D-4D36-9AF9-D600C90C3040Q36441343-DE5046C7-81E1-47C8-A8C4-CF9BDA4A77BBQ36480080-C1372D4C-3054-43E5-A858-ED021FA21E34Q36600436-E82237BD-2243-438F-9A79-F0989600F84DQ36614445-F9CF952C-C12A-4ADF-8CC3-AA58F38656E3Q36675432-A836FE2A-3BB3-4E50-98A0-AD8FA9C9A881Q36869329-62918EB1-A5D8-430F-B9A9-87A8E9996EC2Q36980730-457FA6DC-8360-44BC-8B57-821BB53D8B31Q37226354-3EE6E80C-0254-465E-9273-AF452C12E77E
P2860
Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Gene therapy strategy for long ...... livery of heme oxygenase gene.
@en
type
label
Gene therapy strategy for long ...... livery of heme oxygenase gene.
@en
prefLabel
Gene therapy strategy for long ...... livery of heme oxygenase gene.
@en
P2093
P356
P1433
P1476
Gene therapy strategy for long ...... livery of heme oxygenase gene.
@en
P2093
Abeel A Mangi
Daniel P Griese
Giorgio Dell'Acqua
Junichi Oyama
Luis G Melo
Lunan Zhang
Mark A Perrella
Matthew D Layne
Michael J Mann
Mojgan Rezvani
P304
P356
10.1161/HC0502.103363
P407
P577
2002-02-01T00:00:00Z